Wolfram Hansel

Title: Wolfram Hansel: Innovator in Potassium Channel Inhibition

Introduction

Wolfram Hansel is a notable inventor based in Kronshagen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target potassium channels in lymphocytes and other cells. His work has implications for treating various diseases, including autoimmune disorders.

Latest Patents

Wolfram Hansel holds a patent for "Substituted 5-alkoxypsoralens as inhibitors of potassium channel activity in lymphocytes and other cells." This patent describes compositions of matter comprising 5-phenylalkoxypsoralen compounds and their method of synthesis and use. The compounds are designed to treat diseases or disorders in both human and veterinary patients, including autoimmune diseases such as multiple sclerosis. The therapeutic effects of these compounds may be attributed to their ability to inhibit potassium channels, particularly the Kv1.3 channel.

Career Highlights

Wolfram Hansel is affiliated with the University of California, where he continues to advance research in his field. His innovative work has led to a deeper understanding of potassium channel inhibition and its potential therapeutic applications.

Collaborations

Some of his notable coworkers include Julia Vennekamp and Heike Wulff. Their collaborative efforts contribute to the ongoing research and development of new therapeutic strategies.

Conclusion

Wolfram Hansel's contributions to the field of medicinal chemistry and his innovative patent on potassium channel inhibitors highlight his role as a significant inventor. His work has the potential to impact the treatment of autoimmune diseases and improve patient outcomes.